Quest Diagnostics Incorporated
DGX
$173.76
-$2.11-1.20%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.18% | 5.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.18% | 5.35% | |||
| Cost of Revenue | 1.60% | 4.96% | |||
| Gross Profit | 0.35% | 6.13% | |||
| SG&A Expenses | 0.87% | 6.25% | |||
| Depreciation & Amortization | 5.41% | 15.63% | |||
| Other Operating Expenses | -150.00% | 300.00% | |||
| Total Operating Expenses | 1.38% | 5.53% | |||
| Operating Income | 0.00% | 4.25% | |||
| Income Before Tax | -3.29% | 0.66% | |||
| Income Tax Expenses | -13.24% | 4.62% | |||
| Earnings from Continuing Operations | -0.42% | -0.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -7.14% | -27.27% | |||
| Net Income | -0.90% | -1.77% | |||
| EBIT | 0.00% | 4.25% | |||
| EBITDA | 0.99% | 5.23% | |||
| EPS Basic | -0.45% | -1.34% | |||
| Normalized Basic EPS | -4.77% | 5.44% | |||
| EPS Diluted | -2.12% | -0.40% | |||
| Normalized Diluted EPS | -4.76% | 4.50% | |||
| Average Basic Shares Outstanding | 0.00% | -0.89% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | 6.67% | 0.00% | |||
| Payout Ratio | 0.01% | 0.02% | |||